A Multinational, Randomized, Double-Blind, Placebo?Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis.
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Cetrorelix (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 08 Jan 2008 Status changed from in progress to completed.
- 22 Jun 2007 Status changed from recruiting to in progress.
- 10 Jan 2007 Status change